Brooks Laboratories Limited Holds 24th AGM on Sep 3, 2026
Brooks Laboratories Limited conducted its 24th Annual General Meeting (AGM) on September 3, 2026, via video conference. Key resolutions included adopting FY26 financial statements and approving related party transactions. Detailed voting results will be submitted separately.
The announcement pertains to the proceedings of a routine Annual General Meeting, which is a standard corporate event. It does not contain new financial results, strategic shifts, or significant corporate actions that would materially impact the company's stock or business operations.
The announcement is a routine disclosure of the proceedings of an Annual General Meeting, which is a standard corporate event. No new material financial information or significant strategic decisions were announced that would sway the sentiment.
Brooks Laboratories Limited held its 24th Annual General Meeting (AGM) on September 3, 2026, commencing at 9:00 AM IST. The meeting was conducted through Video Conferencing (VC) / Other Audio-Visual Means (OAVM) in compliance with regulatory guidelines. Dr. Usha Singh, Non-Executive Independent Director, chaired the proceedings.
Several Directors and Key Management Personnel (KMP) were present, including Mr. Bhushan Singh Rana (Wholetime Director), Mr. Manav Mahajan (Non-Executive Independent Director), Mr. Lalit Mahajan (Non-Executive Independent Director), Mr. Jitendra Pratap Singh (Wholetime Director), Dr. Durga Shankar Maity (Wholetime Director), Mr. Prashant Rathi (CEO & CFO), and Ms. Krutika Rane (Company Secretary). The Secretarial Auditor and Statutory Auditor were also in attendance.
319 Members were present at the AGM. The meeting addressed several ordinary resolutions, including the adoption of annual audited standalone and consolidated financial statements for the period ending March 31, 2026, the re-appointment of Mr. Jitendrapratap Rambahadur Singh, ratification of Cost Auditors' remuneration, and approval of related party transactions. Additionally, remuneration approvals for Mr. Atul Ranchal (President – Strategy) and Mr. Rajesh Mahajan (President – Trading) under Section 188(1)(f) of the Companies Act, 2013, were proposed.
Shareholders had the opportunity to express their views and seek clarifications. The company provided remote e-voting facilities and e-voting during the AGM. The detailed voting results, along with the Scrutinizer's Report, will be submitted separately within two working days of the meeting's conclusion, and will also be uploaded on the company's website and the e-voting platform. The meeting concluded at 9:15 AM IST.
A plain-language summary of a public exchange filing by Brooks Laboratories Limited. Read the original for the full detail.